{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:15:10Z","timestamp":1793196910132,"version":"4.5.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35 GM141478"],"award-info":[{"award-number":["R35 GM141478"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL126795"],"award-info":[{"award-number":["R01 HL126795"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL181134"],"award-info":[{"award-number":["R01 HL181134"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["26PRE1563237"],"award-info":[{"award-number":["26PRE1563237"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Severe hemolysis is a life-threatening condition with limited therapeutic options. Although haptoglobin and hemopexin sequester hemoglobin and heme, these protective systems are rapidly saturated during acute hemolysis, leading to the accumulation of cytotoxic free heme. In this study, we identify scavenger receptor BI (SR-BI) as a critical mediator of free heme clearance. SR-BI binds heme and facilitates its hepatic uptake under pathological conditions. Mice lacking hepatic SR-BI exhibit impaired heme clearance and increased susceptibility to heme- and hemolysis-induced lethality. Pharmacological upregulation of hepatic SR-BI via imatinib or adenoviral delivery confers protection against heme toxicity. Using a humanized model of sickle cell disease (SCD), we further demonstrate that sickle hepatopathy significantly reduces hepatic SR-BI expression compared to non-SCD HbAA littermates, potentially increasing vulnerability to heme-induced injury. Notably, adenoviral-mediated SR-BI upregulation rescues SCD mice from heme toxicity. These findings reveal a previously unrecognized mechanism of heme detoxification via hepatic SR-BI and identify a promising therapeutic target for hemolytic disorders.<\/jats:p>","DOI":"10.1038\/s41467-026-76099-x","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T10:57:18Z","timestamp":1785149838000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Identification of scavenger receptor BI as a scavenger of free heme that is essential for protection against hemolysis"],"prefix":"10.1038","volume":"17","author":[{"given":"Misa","family":"Ito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6185-7069","authenticated-orcid":false,"given":"Jianyao","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander H.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4128-7269","authenticated-orcid":false,"given":"Chang-Guo","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ailing","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preetha","family":"Shridas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenheng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingcui","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott M.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9313-3843","authenticated-orcid":false,"given":"Jianhang","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4978-6177","authenticated-orcid":false,"given":"Chieko","family":"Mineo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1157-4002","authenticated-orcid":false,"given":"Philip W.","family":"Shaul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6899-7332","authenticated-orcid":false,"given":"Xiang-an","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"key":"76099_CR1","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1001\/jama.293.13.1653","volume":"293","author":"RP Rother","year":"2005","unstructured":"Rother, R. P., Bell, L., Hillmen, P. & Gladwin, M. T. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA 293, 1653\u20131662 (2005).","journal-title":"JAMA"},{"key":"76099_CR2","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1182\/blood-2012-11-451229","volume":"121","author":"DJ Schaer","year":"2013","unstructured":"Schaer, D. J., Buehler, P. W., Alayash, A. I., Belcher, J. D. & Vercellotti, G. M. Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins. Blood 121, 1276\u20131284 (2013).","journal-title":"Blood"},{"key":"76099_CR3","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1089\/ars.2012.4605","volume":"18","author":"A Etzerodt","year":"2013","unstructured":"Etzerodt, A. et al. Plasma clearance of hemoglobin and haptoglobin in mice and effect of CD163 gene targeting disruption. Antioxid. Redox Signal 18, 2254\u20132263 (2013).","journal-title":"Antioxid. Redox Signal"},{"key":"76099_CR4","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1182\/blood-2005-03-1185","volume":"106","author":"V Hvidberg","year":"2005","unstructured":"Hvidberg, V. et al. Identification of the receptor scavenging hemopexin-heme complexes. Blood 106, 2572\u20132579 (2005).","journal-title":"Blood"},{"key":"76099_CR5","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/35051594","volume":"409","author":"M Kristiansen","year":"2001","unstructured":"Kristiansen, M. et al. Identification of the haemoglobin scavenger receptor. Nature 409, 198\u2013201 (2001).","journal-title":"Nature"},{"key":"76099_CR6","doi-asserted-by":"publisher","first-page":"523652","DOI":"10.1155\/2013\/523652","volume":"2013","author":"JH Thomsen","year":"2013","unstructured":"Thomsen, J. H., Etzerodt, A., Svendsen, P. & Moestrup, S. K. The haptoglobin-CD163-heme oxygenase-1 pathway for hemoglobin scavenging. Oxid. Med. Cell Longev. 2013, 523652 (2013).","journal-title":"Oxid. Med. Cell Longev."},{"key":"76099_CR7","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3389\/fphar.2014.00061","volume":"5","author":"D Chiabrando","year":"2014","unstructured":"Chiabrando, D., Vinchi, F., Fiorito, V., Mercurio, S. & Tolosano, E. Heme in pathophysiology: a matter of scavenging, metabolism and trafficking across cell membranes. Front. Pharmacol. 5, 61 (2014).","journal-title":"Front. Pharmacol."},{"key":"76099_CR8","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1182\/hematology.2023000499","volume":"2023","author":"F Pirenne","year":"2023","unstructured":"Pirenne, F. & Pondarre, C. Alloimmunization and hyperhemolysis in sickle cell disease. Hematol. Am. Soc. Hematol. Educ. Program 2023, 653\u2013659 (2023).","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"76099_CR9","doi-asserted-by":"publisher","first-page":"4201","DOI":"10.1182\/blood-2002-04-1270","volume":"100","author":"E Tolosano","year":"2002","unstructured":"Tolosano, E. et al. Enhanced splenomegaly and severe liver inflammation in haptoglobin\/hemopexin double-null mice after acute hemolysis. Blood 100, 4201\u20134208 (2002).","journal-title":"Blood"},{"key":"76099_CR10","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1126\/science.271.5248.518","volume":"271","author":"S Acton","year":"1996","unstructured":"Acton, S. et al. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 271, 518\u2013520 (1996).","journal-title":"Science"},{"key":"76099_CR11","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1146\/annurev.biochem.68.1.523","volume":"68","author":"M Krieger","year":"1999","unstructured":"Krieger, M. CHARTING THE FATE OF THE \u201cGOOD CHOLESTEROL\u201d: Identification and Characterization of the High-Density Lipoprotein Receptor SR-BI. Annu. Rev. Biochem. 68, 523\u2013558 (1999).","journal-title":"Annu. Rev. Biochem."},{"key":"76099_CR12","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1210\/er.2001-0037","volume":"24","author":"A Rigotti","year":"2003","unstructured":"Rigotti, A., Miettinen, H. E. & Krieger, M. The role of the high-density lipoprotein receptor SR-BI in the lipid metabolism of endocrine and other tissues. Endocr. Rev. 24, 357\u2013387 (2003).","journal-title":"Endocr. Rev."},{"key":"76099_CR13","doi-asserted-by":"publisher","unstructured":"Guo, L., Wang, Q. & Li, X.-A. The Role of SR-BI in sepsis: leveraging mechanistic insights to advance precision steroid therapy. Front. Immunol. 16, https:\/\/doi.org\/10.3389\/fimmu.2025.1643395 (2025).","DOI":"10.3389\/fimmu.2025.1643395"},{"key":"76099_CR14","doi-asserted-by":"publisher","first-page":"13441","DOI":"10.3390\/ijms252413441","volume":"25","author":"D Hao","year":"2024","unstructured":"Hao, D., Xue, J.-Y., Wang, Q., Guo, L. & Li, X.-A. The role of scavenger receptor BI in sepsis. Int. J. Mol. Sci. 25, 13441 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"76099_CR15","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41586-019-1140-4","volume":"569","author":"L Huang","year":"2019","unstructured":"Huang, L. et al. SR-B1 drives endothelial cell LDL transcytosis via DOCK4 to promote atherosclerosis. Nature 569, 565\u2013569 (2019).","journal-title":"Nature"},{"key":"76099_CR16","doi-asserted-by":"publisher","first-page":"e60","DOI":"10.1161\/01.RES.0000219310.00308.10","volume":"98","author":"X-A Li","year":"2006","unstructured":"Li, X.-A., Guo, L., Asmis, R., Nikolova-Karakashian, M. & Smart, E. J. Scavenger receptor BI prevents nitric oxide\u2013induced cytotoxicity and endotoxin-induced death. Circ. Res. 98, e60\u2013e65 (2006).","journal-title":"Circ. Res."},{"key":"76099_CR17","doi-asserted-by":"crossref","unstructured":"Cai, L., Ji, A., de Beer, F., Tannock, L. & van der westhuyzen, D. SR-BI Protects Against Endotoxemia in Mice Through its Roles in Glucocorticoid Production and Hepatic Clearance, (2008).","DOI":"10.1172\/JCI31539"},{"key":"76099_CR18","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1194\/jlr.M056689","volume":"56","author":"H Tao","year":"2015","unstructured":"Tao, H. et al. Macrophage SR-BI mediates efferocytosis via Src\/PI3K\/Rac1 signaling and reduces atherosclerotic lesion necrosis. J. Lipid Res. 56, 1449\u20131460 (2015).","journal-title":"J. Lipid Res."},{"key":"76099_CR19","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/nature12684","volume":"504","author":"D Neculai","year":"2013","unstructured":"Neculai, D. et al. Structure of LIMP-2 provides functional insights with implications for SR-BI and CD36. Nature 504, 172\u2013176 (2013).","journal-title":"Nature"},{"key":"76099_CR20","doi-asserted-by":"publisher","first-page":"15422","DOI":"10.1073\/pnas.222421399","volume":"99","author":"TJF Nieland","year":"2002","unstructured":"Nieland, T. J. F., Penman, M., Dori, L., Krieger, M. & Kirchhausen, T. Discovery of chemical inhibitors of the selective transfer of lipids mediated by the HDL receptor SR-BI. Proc. Natl. Acad. Sci. USA 99, 15422\u201315427 (2002).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"76099_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00277-021-04667-w","volume":"101","author":"N Yildirim","year":"2022","unstructured":"Yildirim, N., Unal, S., Yalcinkaya, A., Karahan, F. & Oztas, Y. Evaluation of the relationship between intravascular hemolysis and clinical manifestations in sickle cell disease: decreased hemopexin during vaso-occlusive crises and increased inflammation in acute chest syndrome. Ann. Hematol. 101, 35\u201341 (2022).","journal-title":"Ann. Hematol."},{"key":"76099_CR22","doi-asserted-by":"publisher","unstructured":"Ramos, S. et al. Targeting circulating labile heme as a defense strategy against malaria. Life Sci. Alliance 7, https:\/\/doi.org\/10.26508\/lsa.202302276 (2024).","DOI":"10.26508\/lsa.202302276"},{"key":"76099_CR23","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3109\/10715762.2013.859386","volume":"48","author":"J Chen-Roetling","year":"2014","unstructured":"Chen-Roetling, J., Cai, Y., Lu, X. & Regan, R. F. Hemin uptake and release by neurons and glia. Free Radic. Res. 48, 200\u2013205 (2014).","journal-title":"Free Radic. Res."},{"key":"76099_CR24","doi-asserted-by":"publisher","first-page":"G1172","DOI":"10.1152\/ajpgi.2001.280.6.G1172","volume":"280","author":"MT Worthington","year":"2001","unstructured":"Worthington, M. T., Cohn, S. M., Miller, S. K., Luo, R. Q. & Berg, C. L. Characterization of a human plasma membrane heme transporter in intestinal and hepatocyte cell lines. Am. J. Physiol. Gastrointest. Liver Physiol. 280, G1172\u2013G1177 (2001).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"76099_CR25","doi-asserted-by":"publisher","first-page":"e1002795","DOI":"10.1371\/journal.ppat.1002795","volume":"8","author":"C Huynh","year":"2012","unstructured":"Huynh, C. et al. Heme uptake by Leishmania amazonensis is mediated by the transmembrane protein LHR1. PLoS Pathog. 8, e1002795 (2012).","journal-title":"PLoS Pathog."},{"key":"76099_CR26","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1074\/jbc.M109.063248","volume":"285","author":"KM O\u2019Callaghan","year":"2010","unstructured":"O\u2019Callaghan, K. M. et al. Heme-binding protein HRG-1 is induced by insulin-like growth factor I and associates with the vacuolar H+-ATPase to control endosomal pH and receptor trafficking.  J. Biol. Chem. 285, 381\u2013391 (2010).","journal-title":"J. Biol. Chem."},{"key":"76099_CR27","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.cell.2005.06.025","volume":"122","author":"M Shayeghi","year":"2005","unstructured":"Shayeghi, M. et al. Identification of an intestinal heme transporter. Cell 122, 789\u2013801 (2005).","journal-title":"Cell"},{"key":"76099_CR28","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1194\/jlr.M019091","volume":"52","author":"L Guo","year":"2011","unstructured":"Guo, L., Chen, M., Song, Z., Daugherty, A. & Li, X. A. C323 of SR-BI is required for SR-BI-mediated HDL binding and cholesteryl ester uptake. J. Lipid Res. 52, 2272\u20132278 (2011).","journal-title":"J. Lipid Res."},{"key":"76099_CR29","doi-asserted-by":"publisher","first-page":"10860","DOI":"10.1021\/bi201264y","volume":"50","author":"J Hu","year":"2011","unstructured":"Hu, J., Zhang, Z., Shen, W. J., Nomoto, A. & Azhar, S. Differential roles of cysteine residues in the cellular trafficking, dimerization, and function of the high-density lipoprotein receptor, SR-BI. Biochemistry 50, 10860\u201310875 (2011).","journal-title":"Biochemistry"},{"key":"76099_CR30","doi-asserted-by":"publisher","first-page":"10044","DOI":"10.1021\/bi301203x","volume":"51","author":"M Yu","year":"2012","unstructured":"Yu, M., Lau, T. Y., Carr, S. A. & Krieger, M. Contributions of a disulfide bond and a reduced cysteine side chain to the intrinsic activity of the high-density lipoprotein receptor SR-BI. Biochemistry 51, 10044\u201310055 (2012).","journal-title":"Biochemistry"},{"key":"76099_CR31","doi-asserted-by":"publisher","first-page":"501","DOI":"10.34067\/KID.0000000000000395","volume":"5","author":"KA Nath","year":"2024","unstructured":"Nath, K. A. et al. Induction of p16Ink4a Gene Expression in Heme Protein-Induced AKI and by Heme: Pathophysiologic Implications. Kidney360 5, 501\u2013514 (2024).","journal-title":"Kidney360"},{"key":"76099_CR32","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1182\/blood-2013-04-495887","volume":"123","author":"JD Belcher","year":"2014","unstructured":"Belcher, J. D. et al. Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease. Blood 123, 377\u2013390 (2014).","journal-title":"Blood"},{"key":"76099_CR33","doi-asserted-by":"publisher","first-page":"4809","DOI":"10.1172\/JCI64578","volume":"123","author":"S Ghosh","year":"2013","unstructured":"Ghosh, S. et al. Extracellular hemin crisis triggers acute chest syndrome in sickle mice. J. Clin. Investig. 123, 4809\u20134820 (2013).","journal-title":"J. Clin. Investig."},{"key":"76099_CR34","doi-asserted-by":"publisher","first-page":"E4110","DOI":"10.1073\/pnas.1405023111","volume":"111","author":"FF Dutra","year":"2014","unstructured":"Dutra, F. F. et al. Hemolysis-induced lethality involves inflammasome activation by heme. Proc. Natl. Acad. Sci. USA 111, E4110\u2013E4118 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"76099_CR35","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.3389\/fimmu.2020.01323","volume":"11","author":"MT Bozza","year":"2020","unstructured":"Bozza, M. T. & Jeney, V. Pro-inflammatory Actions of Heme and Other Hemoglobin-Derived DAMPs. Front. Immunol. 11, 1323 (2020).","journal-title":"Front. Immunol."},{"key":"76099_CR36","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1161\/ATVBAHA.123.318780","volume":"43","author":"JD Dimitrov","year":"2023","unstructured":"Dimitrov, J. D., Roumenina, L. T., Perrella, G. & Rayes, J. Basic mechanisms of hemolysis-associated thrombo-inflammation and immune dysregulation. Arterioscl. Throm. Vas. 43, 1349\u20131361 (2023).","journal-title":"Arterioscl. Throm. Vas."},{"key":"76099_CR37","doi-asserted-by":"publisher","unstructured":"Mikhailova, D. M. et al. Hematin- and hemin-induced spherization and hemolysis of human erythrocytes are independent of extracellular calcium concentration. Cells 13, https:\/\/doi.org\/10.3390\/cells13060554 (2024).","DOI":"10.3390\/cells13060554"},{"key":"76099_CR38","doi-asserted-by":"publisher","unstructured":"Sucharski, H. C. et al. Imatinib promotes reverse cholesterol transport and elevates Sr-bi. Arterioscl. Throm. 42, https:\/\/doi.org\/10.1161\/atvb.42.suppl_1.423 (2022).","DOI":"10.1161\/atvb.42.suppl_1.423"},{"key":"76099_CR39","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1182\/blood-2004-08-3097","volume":"105","author":"M Deininger","year":"2005","unstructured":"Deininger, M., Buchdunger, E. & Druker, B. J. The development of imatinib as a therapeutic agent for chronic myeloid leukemia. Blood 105, 2640\u20132653 (2005).","journal-title":"Blood"},{"key":"76099_CR40","doi-asserted-by":"publisher","first-page":"C494","DOI":"10.1152\/ajpcell.00175.2022","volume":"323","author":"T Pradhan-Sundd","year":"2022","unstructured":"Pradhan-Sundd, T., Kato, G. J. & Novelli, E. M. Molecular mechanisms of hepatic dysfunction in sickle cell disease: lessons from Townes mouse model. Am. J. Physiol. Cell Physiol. 323, C494\u2013C504 (2022).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"76099_CR41","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1182\/hematology.2019000037","volume":"2019","author":"AR Suddle","year":"2019","unstructured":"Suddle, A. R. Management of liver complications in sickle cell disease. Hematol. Am. Soc. Hematol. Educ. Program 2019, 345\u2013350 (2019).","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"76099_CR42","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1182\/blood-2013-04-498105","volume":"122","author":"L Vincent","year":"2013","unstructured":"Vincent, L. et al. Mast cell activation contributes to sickle cell pathobiology and pain in mice. Blood 122, 1853\u20131862 (2013).","journal-title":"Blood"},{"key":"76099_CR43","doi-asserted-by":"publisher","first-page":"e848","DOI":"10.1097\/HS9.0000000000000848","volume":"7","author":"E Federti","year":"2023","unstructured":"Federti, E. et al. In humanized sickle cell mice, imatinib protects against sickle cell-related injury. Hemasphere 7, e848 (2023).","journal-title":"Hemasphere"},{"key":"76099_CR44","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/MAJ.0000000000000228","volume":"347","author":"M Murphy","year":"2014","unstructured":"Murphy, M., Close, J., Lottenberg, R. & Rajasekhar, A. Effectiveness of imatinib therapy for sickle cell anemia and chronic myeloid leukemia. Am. J. Med. Sci. 347, 254\u2013255 (2014).","journal-title":"Am. J. Med. Sci."},{"key":"76099_CR45","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/j.1365-2141.2011.08670.x","volume":"155","author":"K Stankovic Stojanovic","year":"2011","unstructured":"Stankovic Stojanovic, K. et al. Chronic myeloid leukaemia and sickle cell disease: could imatinib prevent vaso-occlusive crisis? Br. J. Haematol. 155, 271\u2013272 (2011).","journal-title":"Br. J. Haematol."},{"key":"76099_CR46","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/bjh.16671","volume":"190","author":"P Noomuna","year":"2020","unstructured":"Noomuna, P. et al. Inhibition of Band 3 tyrosine phosphorylation: a new mechanism for treatment of sickle cell disease. Br. J. Haematol. 190, 599\u2013609 (2020).","journal-title":"Br. J. Haematol."},{"key":"76099_CR47","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.htct.2023.06.007","volume":"46","author":"M Karimi","year":"2024","unstructured":"Karimi, M., Bahadoram, M., Mafakher, L. & Rastegar, M. Impact of Imatinib on reducing the painful crisis in patients with sickle cell disease. Hematol. Transfus. Cell Ther. 46, 387\u2013392 (2024).","journal-title":"Hematol. Transfus. Cell Ther."},{"key":"76099_CR48","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1182\/bloodadvances.2024013435","volume":"9","author":"A Grunenwald","year":"2025","unstructured":"Grunenwald, A. et al. Transcriptomic atlas reveals organ-specific disease tolerance in sickle cell mice. Blood Adv. 9, 1405\u20131419 (2025).","journal-title":"Blood Adv."},{"key":"76099_CR49","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.cell.2016.12.034","volume":"168","author":"MU Muckenthaler","year":"2017","unstructured":"Muckenthaler, M. U., Rivella, S., Hentze, M. W. & Galy, B. A Red Carpet for Iron Metabolism. Cell 168, 344\u2013361 (2017).","journal-title":"Cell"},{"key":"76099_CR50","doi-asserted-by":"crossref","unstructured":"Vercellotti, G. M. et al. Hemopexin gene therapy inhibits inflammation and vaso-occlusion in transgenic sickle cell mice. Blood 126, 412 (2015).","DOI":"10.1182\/blood.V126.23.412.412"},{"key":"76099_CR51","doi-asserted-by":"crossref","unstructured":"Ghosh, S. et al. Hemopexin replacement therapy protects sickle cell disease mice from acute kidney injury. Blood 134, (2019).","DOI":"10.1182\/blood-2019-127161"},{"key":"76099_CR52","doi-asserted-by":"publisher","first-page":"630","DOI":"10.3390\/jcm11030630","volume":"11","author":"T Gentinetta","year":"2022","unstructured":"Gentinetta, T. et al. Plasma-derived hemopexin as a candidate therapeutic agent for acute vaso-occlusion in sickle cell disease: preclinical evidence. J. Clin. Med. 11, 630 (2022).","journal-title":"J. Clin. Med."},{"key":"76099_CR53","doi-asserted-by":"publisher","first-page":"H671","DOI":"10.1152\/ajpheart.00280.2019","volume":"318","author":"KA Nath","year":"2020","unstructured":"Nath, K. A. et al. Antithrombotic effects of heme-degrading and heme-binding proteins. Am. J. Physiol. Heart C. 318, H671\u2013H681 (2020).","journal-title":"Am. J. Physiol. Heart C."},{"key":"76099_CR54","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1161\/CIRCULATIONAHA.112.130179","volume":"127","author":"F Vinchi","year":"2013","unstructured":"Vinchi, F. et al. Hemopexin therapy improves cardiovascular function by preventing heme-induced endothelial toxicity in mouse models of hemolytic diseases. Circulation 127, 1317\u20131329 (2013).","journal-title":"Circulation"},{"key":"76099_CR55","doi-asserted-by":"publisher","first-page":"289","DOI":"10.2353\/ajpath.2008.071130","volume":"173","author":"F Vinchi","year":"2008","unstructured":"Vinchi, F., Gastaldi, S., Silengo, L., Altruda, F. & Tolosano, E. Hemopexin prevents endothelial damage and liver congestion in a mouse model of heme overload. Am. J. Pathol. 173, 289\u2013299 (2008).","journal-title":"Am. J. Pathol."},{"key":"76099_CR56","doi-asserted-by":"publisher","first-page":"437","DOI":"10.2119\/molmed.2016.00063","volume":"22","author":"GM Vercellotti","year":"2016","unstructured":"Vercellotti, G. M. et al. Hepatic Overexpression of Hemopexin Inhibits Inflammation and Vascular Stasis in Murine Models of Sickle Cell Disease. Mol. Med. 22, 437\u2013451 (2016).","journal-title":"Mol. Med."},{"key":"76099_CR57","doi-asserted-by":"publisher","first-page":"1474569","DOI":"10.3389\/fphys.2024.1474569","volume":"15","author":"J Xue","year":"2024","unstructured":"Xue, J. & Li, X. A. Therapeutics for sickle cell disease intravascular hemolysis. Front Physiol. 15, 1474569 (2024).","journal-title":"Front Physiol."},{"key":"76099_CR58","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3389\/fphys.2015.00187","volume":"6","author":"A Smith","year":"2015","unstructured":"Smith, A. & McCulloh, R. J. Hemopexin and haptoglobin: allies against heme toxicity from hemoglobin not contenders. Front Physiol. 6, 187 (2015).","journal-title":"Front Physiol."},{"key":"76099_CR59","doi-asserted-by":"publisher","first-page":"33068","DOI":"10.1074\/jbc.272.52.33068","volume":"272","author":"G Cao","year":"1997","unstructured":"Cao, G. et al. Structure and localization of the human gene encoding SR-BI\/CLA-1. Evidence for transcriptional control by steroidogenic factor 1. J. Biol. Chem. 272, 33068\u201333076 (1997).","journal-title":"J. Biol. Chem."},{"key":"76099_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.107974","volume":"300","author":"Q Wang","year":"2024","unstructured":"Wang, Q. et al. Elevated free cholesterol levels due to impaired reverse cholesterol transport are a risk factor for polymicrobial sepsis in mice. J. Biol. Chem. 300, 107974 (2024).","journal-title":"J. Biol. Chem."},{"key":"76099_CR61","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1194\/jlr.M400361-JLR200","volume":"46","author":"R Out","year":"2005","unstructured":"Out, R. et al. Adenovirus-mediated hepatic overexpression of scavenger receptor class B type I accelerates chylomicron metabolism in C57BL\/6J mice. J. Lipid Res. 46, 1172\u20131181 (2005).","journal-title":"J. Lipid Res."},{"key":"76099_CR62","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3324\/haematol.2014.114728","volume":"100","author":"EM Sparkenbaugh","year":"2015","unstructured":"Sparkenbaugh, E. M. et al. Excess of heme induces tissue factor-dependent activation of coagulation in mice. Haematologica 100, 308\u2013314 (2015).","journal-title":"Haematologica"},{"key":"76099_CR63","doi-asserted-by":"publisher","first-page":"11058","DOI":"10.1074\/jbc.M110985200","volume":"277","author":"XA Li","year":"2002","unstructured":"Li, X. A. et al. High density lipoprotein binding to scavenger receptor, Class B, type I activates endothelial nitric-oxide synthase in a ceramide-dependent manner. J. Biol. Chem. 277, 11058\u201311063 (2002).","journal-title":"J. Biol. Chem."},{"key":"76099_CR64","doi-asserted-by":"publisher","first-page":"100086","DOI":"10.1016\/j.xpro.2020.100086","volume":"1","author":"M Charni-Natan","year":"2020","unstructured":"Charni-Natan, M. & Goldstein, I. Protocol for Primary Mouse Hepatocyte Isolation. STAR Protoc. 1, 100086 (2020).","journal-title":"STAR Protoc."},{"key":"76099_CR65","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1093\/infdis\/jiad369","volume":"229","author":"D Hao","year":"2023","unstructured":"Hao, D. et al. Relative adrenal insufficiency is a risk factor for pediatric sepsis - a proof-of-concept study. J. Infect. Dis. 229, 1166\u20131177 (2023).","journal-title":"J. Infect. Dis."},{"key":"76099_CR66","doi-asserted-by":"publisher","unstructured":"Hao, D. et al. The ACTH test fails to diagnose adrenal insufficiency and augments cytokine production in sepsis. JCI Insight 10, https:\/\/doi.org\/10.1172\/jci.insight.187487 (2025).","DOI":"10.1172\/jci.insight.187487"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76099-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76099-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76099-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T11:03:54Z","timestamp":1787828634000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76099-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["76099"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-76099-x","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"assertion":[{"value":"24 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"9108"}}